Format

Send to

Choose Destination
Clin Neuropharmacol. 1991;14 Suppl 1:S62-76.

Nerve growth factor and Alzheimer's disease.

Author information

1
Andrus Gerontology Center, University of Southern California, Los Angeles, 90089.

Abstract

Clinical trials with cholinergic agents suggest that cholinergic hypertrophy may be beneficial in the treatment of Alzheimer's disease (AD). Recent findings substantiate the view that nerve growth factor (NGF) selectively acts on cholinergic neurons. In adult rats and primates, intraventricular administration of nerve growth factor produces trophic actions on cholinergic neurons and prevents age related neuronal atrophy. These findings suggest the possibility of the eventual development of pharmacological applications of nerve growth factor for the treatment of AD.

PMID:
1913710
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center